New online community to provide important support to patients with chronic pancreatitis.


NEW YORK, November 16, 2021 / PRNewswire / – The nonprofit Mission: Cure, with the support of Aimmune Therapeutics, Inc., a Nestlé Health Science company, has launched a new online patient community on the HealthUnlocked network, which will provide a support and valuable information for people living with pancreatitis, helping them to live healthier lives. The online community is an indispensable space for patients suffering from this debilitating and isolating disease to connect and share their journey with pancreatitis in a supportive environment. Patients can join the community by following this link:

Mission: Heal

“Chronic pancreatitis is a destructive chronic inflammatory disease of the pancreas associated with multiple consequences, including exocrine pancreatic insufficiency. Establishing a community portal for patients with exocrine pancreatic insufficiency due to chronic pancreatitis will help patients in many ways, including: identifying symptoms, improving communications with other patients with similar conditions and improve patient care, ”said Dr Samer AlKaade, MD., Mercy Clinic Gastroenterology, Advanced Endoscopy, St. Louis, Missouri, UNITED STATES.

Mission: Heal is a non-profit organization that works to improve the lives of people with pancreatitis and find effective therapies for the disease. The community will be administered and moderated by Mission: Cure – the organization will share valuable educational resources for patients as well as their progress towards a cure for chronic pancreatitis. Megan Golden, CEO and co-founder of Mission: Cure, said: “For patients, the community will be a place where you can come and talk about the health issues that affect you – whether you have chronic pancreatitis, acute pancreatitis, or related conditions like exocrine pancreatic insufficiency – also known as PEV. “

Coming to the community, people will also benefit from HealthUnlocked technology, which makes personalized health recommendations, directs people to useful information, connects them with others, and highlights research that may be of interest to them.

“Aimmune is committed to better understanding the impact of EPI on the quality of life of patients with chronic pancreatitis”, noted Mohamed yassine, MD. Senior Vice President, Global Medical Affairs for Aimmune Therapeutics. This community is a distinct additional opportunity outside of the traditional PACT-CP registry, offered by Aimmune Therapeutics, to learn from patients in their own words about how acute and chronic pancreatitis affects their lives.

Aimmune Therapeutics, Inc., a Nestlé Health Science Company, is a biopharmaceutical company that develops pharmaceutical therapies to prevent, manage and treat diseases related to diet and metabolism, including exocrine pancreatic insufficiency. Aimmune markets pancreatic enzyme replacement therapy (PERT), an FDA and EU approved drug for peanut allergy, and other investigational therapies in development.

Health Unlocked is an innovative social health network of over 1.4 million patients, representing over 250 disease states and conditions with over 300 patient advocacy groups. These patients share paradigms of treatment, symptom management and quality of life issues on a global scale. HealthUnlocked is owned by CorEvitas, LLC, within their patient experience unit, HealthiVibe. Clinicians, the NHS (including NHS Choices), insurers and industry can use HealthUnlocked to securely connect online with patients.

Contact: Megan Golden, Mission: Heal
E-mail: [email protected]
Call: +1 401 375-2873

HealthUnlocked (PRNewsfoto / Corrona, LLC)

HealthUnlocked (PRNewsfoto / Corrona, LLC)



View original content to download multimedia:

SOURCE Mission: Heal


Comments are closed.